Izrael - hebrejščina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax

Izrael - hebrejščina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax

Izrael - hebrejščina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax

Izrael - hebrejščina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax

Izrael - hebrejščina - Ministry of Health

cure medical & technical supply - acetic acid 5.6 ml/l; arginine 8.4 g/l - solution for infusion - amino acids - vamin 14ef is indicated as a source of amino acids for protein synthesis in patients needing intravenous nutrition. vamin 14ef is particulary suitable for patients with moderaterly increased amino acid requirements.

Izrael - hebrejščina - Ministry of Health

lapidot medical import and marketing ltd - acetyltyrosine 1.23 g/l; arginine 9.2 g/l - solution for infusion - solutions for parenteral nutrition - parenteral nutrition and fluid substitution prophylaxis and therapy of protein deficiency or increased protein needs.

Izrael - hebrejščina - Ministry of Health

romat ltd - acetylmethionine 20 mg/ml; arginine 2.4 mg/ml - solution for injection - supplement of vitamins, amino acid and sugars

Izrael - hebrejščina - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 200 mg/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Izrael - hebrejščina - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 200 mg/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Izrael - hebrejščina - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - אבקה מיובשת בהקפאה להכנת תרכיז לאינפוזיה - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.